Hikma Pharmaceuticals Plc Director/PDMR Shareholding (9861Q)
December 05 2016 - 7:34AM
UK Regulatory
TIDMHIK
RNS Number : 9861Q
Hikma Pharmaceuticals Plc
05 December 2016
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
The attached individual notification made under article 19.1 of
the Market Abuse Regulation ("MAR") relates to the purchase by HMS
Holdings SAL of Ordinary Shares of 10 pence each in Hikma
Pharmaceuticals PLC. The Chairman and Chief Executive, and the Vice
Chairman shareholders in HMS Holdings SAL. This announcement is
made in accordance with article 19.3 of MAR.
Said Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Said Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Chairman and Chief Executive Officer
/ PDMR
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Acquisition by HMS Holdings SAL of
the transaction 350,000 Ordinary Shares of 10 pence
each in Hikma Pharmaceuticals PLC.
The Chairman and Chief Executive
is a shareholder in HMS Holdings
SAL with an equity interest of 29.16%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP16.74
volume(s) Volume(s): 350,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 350,000
information Price: GBP16.74
--- --------------------- ----------------------------------------
e) Date of the 2 December 2016
transaction
--- --------------------- ----------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- ----------------------------------------
Mazen Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Mazen Darwazah
--- --------------------- -------------------------------------
2 Reason for the notification
--- ------------------------------------------------------------
a) Position/status Executive Vice Chairman / PDMR
--- --------------------- -------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- -------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- -------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- -------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- -------------------------------------
b) Nature of Acquisition by HMS Holdings SAL of
the transaction 350,000 Ordinary Shares of 10 pence
each in Hikma Pharmaceuticals PLC.
The Vice Chairman is a shareholder
in HMS Holdings SAL with an equity
interest of 29.16%.
--- --------------------- -------------------------------------
c) Price(s) and Price(s): GBP16.74
volume(s) Volume(s): 350,000
--- --------------------- -------------------------------------
d) Aggregated Aggregated volume: 350,000
information Price: GBP16.74
--- --------------------- -------------------------------------
e) Date of the 2 December 2016
transaction
--- --------------------- -------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- -------------------------------------
Peter Speirs, Company Secretary, Responsible for releasing this
announcement
5 December 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDBDDDXGBGLU
(END) Dow Jones Newswires
December 05, 2016 07:34 ET (12:34 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024
